Celcuity Inc (CELC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CELC | KYMR | PTGX | ||
| Company | Celcuity Inc | Kymera Therapeutics Inc | Protagonist Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 131.09 | 81.83 | 100.64 | ||
| High | 134.97 | 82.92 | 102.40 | ||
| Low | 126.77 | 80.79 | 98.84 | ||
| Latest | 132.88 | 81.42 | 99.56 | ||
| Change | +1.97 | -0.04 | -0.85 | ||
| % Change | +1.50% | -0.05% | -0.85% | ||
| Volume | 1,419,200 | 587,300 | 597,700 | ||
| 20-Day Average Volume | 1,255,755 | 486,365 | 519,030 | ||
| Previous Close | 130.91 | 81.46 | 100.41 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 133.85 | 82.36 | 100.88 | ||
| 20-Day Raw Stochastic | 45.89% | 36.14% | 31.77% | ||
| 20-Day Relative Strength | 53.48 | 47.67 | 49.01 | ||
| Weighted Alpha | +277.64 | +69.09 | +77.42 | ||
| Today's Opinion | 88% Buy | 24% Buy | 56% Buy | ||
| Previous Opinion | 88% Buy | 40% Buy | 56% Buy | ||
| Last Month's Opinion | 88% Buy | 64% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.77% since 05/21/26 | +1.00% since 05/21/26 | -2.40% since 05/21/26 | ||
| Low | 126.77 on 05/29/26 | 77.99 on 05/26/26 | 97.93 on 05/26/26 | ||
| High | 142.82 on 05/22/26 | 82.92 on 05/29/26 | 103.71 on 05/28/26 | ||
| 1-Month | |||||
| %Chg | +11.66% since 04/29/26 | -0.11% since 04/29/26 | +1.06% since 04/29/26 | ||
| Low | 116.50 on 04/30/26 | 76.87 on 05/19/26 | 96.69 on 05/19/26 | ||
| High | 151.02 on 05/04/26 | 89.46 on 05/11/26 | 105.72 on 05/14/26 | ||
| 3-Month | |||||
| %Chg | +18.95% since 02/27/26 | -10.87% since 02/27/26 | +8.12% since 02/27/26 | ||
| Low | 100.01 on 03/24/26 | 73.31 on 03/24/26 | 87.82 on 03/06/26 | ||
| High | 151.02 on 05/04/26 | 91.00 on 03/02/26 | 107.84 on 04/01/26 | ||
| 6-Month | |||||
| %Chg | +31.38% since 11/28/25 | +19.95% since 11/28/25 | +10.62% since 11/28/25 | ||
| Low | 96.70 on 12/01/25 | 63.69 on 12/02/25 | 77.00 on 02/23/26 | ||
| High | 151.02 on 05/04/26 | 103.00 on 12/08/25 | 107.84 on 04/01/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,480,025 | 6,697,446 | 6,402,802 | ||
| Shares Outstanding, K | 48,766 | 82,258 | 64,311 | ||
| Annual Sales | 0 | 39,210,000 | 46,020,000 | ||
| Annual Net Income | -177,040,000 | -311,350,000 | -130,150,000 | ||
| Last Quarter Sales | 0 | 34,370,000 | 56,370,000 | ||
| Last Quarter Net Income | -52,840,000 | -69,230,000 | 3,780,000 | ||
| 60-Month Beta | 0.09 | 2.06 | 1.89 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.97 on 05/14/26 | -0.71 on 04/30/26 | 0.05 on 05/05/26 | ||
| Earnings Date | 08/13/26 | 08/10/26 | 08/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||